TrialBMC cancer2023

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.

Tina Kringelbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.